Clover Health Investments Return on Tangible Equity 2020-2024 | CLOV

Current and historical return on tangible equity values for Clover Health Investments (CLOV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Clover Health Investments Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-03-31 $-0.16B $0.29B -53.63%
2023-12-31 $-0.21B $0.28B -71.00%
2023-09-30 $-0.23B $0.30B -72.41%
2023-06-30 $-0.26B $0.31B -77.97%
2023-03-31 $-0.34B $0.30B -92.63%
2022-12-31 $-0.34B $0.34B -82.74%
2022-09-30 $-0.44B $0.39B -96.29%
2022-06-30 $-0.40B $0.42B -86.61%
2022-03-31 $-0.62B $0.49B -141.38%
2021-12-31 $-0.59B $0.54B -127.90%
2021-09-30 $-0.53B $0.41B -306.84%
2021-06-30 $-0.48B $0.31B -674.65%
2021-03-31 $-0.16B $0.59B 2836.36%
2020-12-31 $-0.14B $-0.62B 89.62%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.431B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.024B 20.33
Inspire Medical Systems (INSP) United States $4.855B 0.00
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.072B 0.00
10x Genomics (TXG) United States $3.022B 0.00
Azenta (AZTA) United States $3.015B 163.85
Olink Holding AB (publ) (OLK) Sweden $2.918B 0.00
Enovis (ENOV) United States $2.779B 20.60
Hims & Hers Health (HIMS) United States $2.603B 0.00
Privia Health (PRVA) United States $2.238B 99.26
Schrodinger (SDGR) United States $1.679B 0.00
Omnicell (OMCL) United States $1.376B 47.56
Phreesia (PHR) United States $1.237B 0.00
Standard BioTools (LAB) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Talkspace (TALK) United States $0.451B 0.00
Health Catalyst (HCAT) United States $0.393B 0.00
Pulmonx (LUNG) United States $0.342B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.300B 0.00
P3 Health Partners (PIII) United States $0.236B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
American Well (AMWL) United States $0.150B 0.00
Augmedix (AUGX) United States $0.128B 0.00
TruBridge (TBRG) United States $0.121B 5.17
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.094B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.049B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.017B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.012B 0.00
Biotricity (BTCY) United States $0.011B 0.00
ETAO (ETAO) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00